Unknown

Dataset Information

Chemoinformatics approach to design and develop vanillin analogs as COX-1 inhibitor.


ABSTRACT:

Background

Coronary Heart Disease (CHD), commonly known as the silent killer, impacted the severity of COVID-19 patients during the pandemic era. Thrombosis or blood clots create the buildup of plaque on the coronary artery walls of the heart, which leads to coronary heart disease. Cyclooxygenase 1 (COX-1) is involved in the production of prostacyclin by systemic arteries; hence, inhibiting the COX-1 enzyme can prevent platelet reactivity mediated by prostacyclin. To obtain good health and well-being, the research of discovery of new drugs for anti-thrombotic still continue.

Objective

This study aims to predict the potential of 17 compounds owned by the vanillin analog to COX-1 receptor using in silico.

Methods

This research employed a molecular docking analysi

SUBMITTER: Norhayati 

PROVIDER: S-EPMC10365673 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature